Jun Qi
Affiliations: | Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States |
Google:
"Jun Qi"Mean distance: (not calculated yet)
Parents
Sign in to add mentorWilliam R. Roush | grad student | 2001-2006 | University of Michigan |
Mohammad Movassaghi | post-doc | 2006-2009 | MIT |
James Bradner | research scientist | Dana-Farber Cancer Institute, Harvard Medical School |
Children
Sign in to add traineeWai-Lung Ng | post-doc | 2016- | Harvard Medical School |
Xiuqi Wang | post-doc | 2023- | Dana Farber Cancer Institute, Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Duplaquet L, So K, Ying AW, et al. (2024) Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer. Cancer Cell |
Souroullas GP, Jeck WR, Parker JS, et al. (2024) Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nature Medicine |
Duplaquet L, So K, Ying AW, et al. (2024) Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer. Biorxiv : the Preprint Server For Biology |
L Vu KA, Kumari K, Liu BH, et al. (2023) SALL4B, not targeted by IMiD, is important for SALL4-mediated tumorigenesis. Biorxiv : the Preprint Server For Biology |
Li M, Yang L, Chan AKN, et al. (2023) Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2206584 |
Feng Y, Cai L, Pook M, et al. (2023) BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma. Biorxiv : the Preprint Server For Biology |
Sevinç K, Sevinç GG, Cavga AD, et al. (2022) BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming. Stem Cell Reports |
Guan X, Cheryala N, Karim RM, et al. (2022) Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity. Journal of Medicinal Chemistry |
Ding J, Cui XG, Chen HJ, et al. (2022) Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma. Cancers. 14 |
Zullow HJ, Sankar A, Ingram DR, et al. (2022) The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Molecular Cell |